Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    10930147 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance
Condition: HIV Infections
Interventions: Drug: Lopinavir/ritonavir;   Drug: Ritonavir;   Drug: Saquinavir;   Drug: Tenofovir disoproxil fumarate;   Drug: Amprenavir

Indicates status has not been verified in more than two years